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Stimulation of m-opioid receptors (OPRMs) brings
powerful pain relief, but it also leads to the develop-
ment of tolerance and addiction. Ensuing with-
drawal in abstinent patients manifests itself with
severe symptoms, including cold hyperalgesia,
often preventing addicted patients from success-
fully completing the rehabilitation. Unsurprisingly,
OPRMs have been a central point of many studies.
Nonetheless, a satisfactory understanding of the
pathways leading to distorted sensory responses
during opiate administration and abstinence is far
from complete. Here, we present a mechanism
that leads to modulation by OPRMs of one of the
sensory responses, thermosensation. Activation of
OPRM1 leads to internalization of a cold-sensor
TRPM8, which can be reversed by a follow-up treat-
ment with the inverse OPRM agonist naloxone.
Knockout of TRPM8 protein leads to a decrease in
morphine-induced cold analgesia. The proposed
pathway represents a universal mechanism that is
probably shared by regulatory pathways modu-
lating general pain sensation in response to opioid
treatment.INTRODUCTION
Morphine and its derivatives act as powerful analgesics, but
also induce profound tolerance and dependence, limiting clin-
ical use of opioids (Martin and Fraser, 1961). Although both
beneficial and detrimental effects are triggered by activation of504 Cell Reports 4, 504–515, August 15, 2013 ª2013 The Authorsm-opioid receptors, they are believed to be mediated by different
signaling pathways. The analgesic effects are predominantly
associated with activation of Gi, the inhibitory G protein for
adenylyl cyclase (Raffa et al., 1994). At the same time, activation
of OPRMs leads to their phosphorylation and subsequent
b-arrestin binding, thus resulting in termination of GPCR signals
(Luttrell and Lefkowitz, 2002). Moreover, OPRMs are known to
desensitize quickly upon activation by opioids (Kenski et al.,
2005; Schulz et al., 2004), which complicates understanding of
sustained analgesic effects and withdrawal syndrome. Unravel-
ing the pathways underlying sustained opioid responses and
withdrawal syndrome will enable development of more effective
and safer drugs.
Distorted thermal sensation is one of the various sensory
responses modulated by opiate application. Patients frequently
describe waves of warmth upon drug administration, as well as
cold chills often in combination with hyperalgesia during with-
drawal, whereas supporting in vivo observations demonstrate
elevated responsivity in cold-pressor tests (Chu et al., 2006;
Pud et al., 2006; Ren et al., 2009). Recently, TRPM8 has been
shown to be responsible for mild cold sensation in animals (Bau-
tista et al., 2007). General in vivo observations revealed that opi-
oids suppress icilin-induced wet-dog shaking (Werkheiser et al.,
2006) and lead to hyperthermia (Rawls and Benamar, 2011).
However, molecular mechanisms that would successfully
explain such observations are lacking. Here, we present evi-
dence for a mechanism regulating thermosensation in response
to chronic OPRM stimulation. Activation of OPRM1 leads to
internalization of a cold-sensor TRPM8, causing cold analgesia
in mice and can be reversed by a follow-up treatment with
inverse OPRM agonist naloxone. Knockout of TRPM8 protein,
in turn, leads to a decrease in morphine-induced cold analgesia.
The proposed pathway represents a universal mechanism that is
likely shared by regulatory pathways modulating general pain
sensation in response to opioid treatment.
Figure 1. Morphine Suppresses TRPM8 Ac-
tivity in Sensory Neurons
(A) Sample traces of TRPM8 currents invoked by
application of 100 mM menthol in DRG neurons.
Compared are currents in control cells (white cir-
cles), cells that were treated with 10 mM morphine
(gray triangles), and cells where morphine treat-
ment was followed by application of 10 mM
naloxone (filled squares). Traces were normalized
to their peaks at the time of menthol application.
(B) Bar plot summarizes the responses to menthol
in control, morphine, and morphine followed by
naloxone-treated cells (n = 8, 6, and 4). Statistical
analysis was performed for the amplitude of the
currents recorded at a time indicated by vertical
arrow in (A).
(C) Sample activity of TRPM8 in excised outside-
out patches. Measurement of basal activity (left)
was followed by application of 10 mM morphine
(middle) for an extended duration (typically 10 min)
and, finally, of menthol (right) to verify the identity
of the recorded single ion channels.
(D) Bar plot comparing average activity in outside-
out patches in response to morphine and menthol,
normalized to basal activity level in each trace
(n = 8).
(E) Sample activity of TRPM8 in cell-attached
patches to DRG neurons shows characteristic
voltage dependence of the channel. *p < 0.05 and
**p < 0.01.
Data are presented as mean ± SEM. See also
Figure S1.RESULTS
Stimulation of OPRM1 Suppresses TRPM8 Activity in
Dorsal Root Ganglion Neurons
To address the issue of abnormal opiate-related thermosensa-
tion, we examined whether TRPM8 activity can be regulated
by OPRM1 in the subpopulation of native rat sensory dorsal
root ganglion (DRG) neurons, mediating cold sensation (e.g.,
Craig, 2002). Studies were carried out on the subset of small
diameter DRG neurons that exhibited menthol-induced ITRPM8
with its characteristic biphysical properties (McKemy et al.,
2002). Figure 1A compares currents evoked by 100 mMmenthol
in the absence and in the presence of 10 mMmorphine. As can be
seen, application of morphine caused a slow reduction of
menthol-evoked current in DRG neurons that, within 10 min,
led to small but significant decrease of the mean ITRPM8 at the
membrane potential of +100 mV (Figure 1B) that provided the
best signal-to-noise ratio, as well as at a more physiological
60 mV (Figures S1A and S1B). Moreover, application of
10 mM naloxone, following this morphine treatment, led to simi-
larly slow restoration of the ITRPM8 to the original levels, as
demonstrated in Figures 1A and 1B.Cell Reports 4, 504–515In order to check how TRPM8 gating
has been altered bymorphine, we studied
the currents in cell-attached patches
made to DRG neurons. These patches
exhibited currents, characteristic ofTRPM8 channel (Ferna´ndez et al., 2011) (Figure 1E). However,
majority of the patches from TRPM8-expressing DRG neurons
exhibited multiple conductance levels, thus precluding true
single-channel analysis of TRPM8 kinetics. This limited our anal-
ysis to characterization of overall probability of TRPM8 opening
(NPopen), which depends on both the channel-gating properties
and the number of active TRPM8 channels within the patch.
The NPopen measurements were carried out in excised outside-
out patches and compared basal TRPM8 activity with that in
morphine before and after menthol application. Figure 1C illus-
trates typical single-channel currents observed in these patches,
and Figure 1D summarizes the average NPopen in the corre-
sponding regions of the acquired patches, normalized to basal
activity in each patch. Figure S1C shows effect of morphine on
menthol-induced TRPM8 currents, and Figure S1D summarizes
NPopen values, normalized to menthol-stimulated activity before
morphine application. Similarly to whole-cell currents, morphine
treatment caused a slow (15% in 10 min) but significant reduc-
tion of overall TRPM8 activity.
To determine if there is any functional consequence of
morphine-dependent suppression of TRPM8 activity, we related
spontaneous (Figure 2A) and menthol-induced (Figure 2B), August 15, 2013 ª2013 The Authors 505
Figure 2. Morphine Suppresses [Ca2+]i Changes in DRG Neurons
(A and B) Spontaneous (A) and menthol-induced (B) action potentials in DRG neurons recorded under current-clamp (top) are associated with Ca2+ spikes
(middle) detected with confocal imaging of fluo-3 fluorescence. Self-normalized (F/F0) images (bottom) were captured during the periods highlighted on the plots
(middle) by gray background (i and ii, respectively). Imaging was performed at 20Hz (A) and 60Hz (B). Note that Ca2+ spikes initiated in subplasmalemmal regions.
(C) Menthol-induced [Ca2+]i changes in DRG neurons with depleted Ca
2+ stores (1 hr incubation with 50 mM of cyclopiazonic acid) were monitored using x-y
imaging (at 0.6 Hz) of fluo-4 fluorescence. The fluorescence intensity (F) was normalized to the averaged fluorescence intensity before menthol application (F0).
The traces (DF/F0) were obtained in control (top), after 2 hr incubation with 10 mMmorphine (middle) and following 2 hr incubation with 10 mM naloxone after 2 hr
morphine pretreatment (bottom). The galleries below the plots demonstrate the images captured at 2 min interval.
(D) Bar-diagram plot compares masses of the fluo-4 signal,
R ðDF=F0Þ, during first 40 min after menthol application in control (n = 15) and following morphine (n =
21) and naloxone (n = 17) treatment. ***p < 0.001. Data are presented as mean ± SD.
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changes in the cell membrane potential to the changes of [Ca2+]i
in DRG neurons and then examined the effects of 2 hr incubation
with 10 mM morphine and 2 hr incubation with 10 mM naloxone
after 2 hr morphine pretreatment on menthol-induced [Ca2+]i
changes in DRG neurons with depleted Ca2+ stores (Figures
2C and 2D). This revealed that spontaneous action potentials
(APs) are associated with Ca2+ spikes initiated at subplamalem-
mal regions and reflecting Ca2+ entry into the cell (Figure 2A).
Application of 100 mM menthol caused membrane depolariza-
tion, which was associated with increased frequency of APs.
Within 2 s, depolarization became so extreme that AP discharge
ceased. The raising phase of [Ca2+]i response associated with
menthol-induced depolarization revealed very brief Ca2+ spikes
coupled to APs (Figure 2B). To monitor how morphine and
naloxone affect TRPM8-linked Ca2+ entry in nonclamped DRG
neurons, we compared menthol-induced [Ca2+]i changes in
fluo-4-loaded DRG neurons with depleted Ca2+ stores (to elimi-
nate contribution of possible Ca2+ release to the recorded
signal). The Ca2+ store depletion was achieved by 1 hr incubation
of the cells with 50 mM of SERCA inhibitor, cyclopiazonic acid.
Under these conditions, continuous (for 45 min) monitoring of
[Ca2+]i changes (Figure 2C) revealed that [Ca
2+]i response to
200 mMmenthol started from a large-amplitude transient, during
which spontaneous Ca2+ spikes ceased. This was followed by a
sustained phase, during which spontaneous Ca2+ spikes recov-
ered and their frequency gradually increased (Figure 2C, top).
This menthol-induced [Ca2+]i response was virtually completely
abolished after 2 hr incubation with 10 mMmorphine (Figure 2C,
middle) but was recovered following 2 hr incubation with 10 mM
naloxone (Figure 2C, bottom). The temporal pattern of the
menthol-induced [Ca2+]i response was complex and was
affected by morphine pretreatment. To quantify the effects we
used the ‘‘signal mass’’ approach, developed previously to
determine the Ca2+ fluxes underlying localized [Ca2+]i transients
in smoothmuscle cells (Amberg et al., 2007; Zou et al., 2004).We
compared integrals of the fluo-4 signal (averagedwithin confocal
optical slice of the cell) during the first 40min after menthol appli-
cation in control, and following morphine and naloxone treat-
ment (Figure 2D). This revealed that TRPM8-linked Ca2+ entry
is significantly (p < 0.001) suppressed by morphine but is
restored by naloxone.
Morphine Suppresses Heterologous TRPM8 Activity in
HEK293 Cells
Having established that stimulation of OPRM1 leads to gradual
decrease of TRPM8 activity in sensory neurons, we utilized a
controlled expression system to study the mechanisms underly-
ing this regulation. HEK293 cells stably expressing human
TRPM8 (HEK293M8) were cultured as described previously (The-
bault et al., 2005) and were transfected with OPRM1 plasmid.
The cells were then pretreated with 10 mM morphine for 40 min
or left untreated. Cold (20C) or menthol (100 mM) -induced
TRPM8 activity was recorded as shown in Figure 3B. Morphine
pretreatment significantly inhibited both cold- and menthol-
induced TRPM8 currents (Figures 3C and 3D, respectively).
This inhibition, however, was not observed in the cells that did
not expressOPRM1 (Figures S2A andS2B), indicating that effect
of morphine on ITRPM8 is mediated by OPRM1. Moreover, sup-pression of TRPM8 currents by morphine could be reversed by
follow-up treatment with an inverse agonist of OPRM, naloxone
(10 mM). Cells incubated for 1 hr with naloxone after or without
morphine pretreatment revealed slightly, but significantly, bigger
TRPM8 currents than those observed in control cells (Figures 3C
and 3D). Additionally, the effect of morphine could be blocked by
a G protein inhibitor pertussis toxin (PTX), as shown in Figures
3B–3D. Interestingly, morphine treatment did not change relative
potency of menthol versus cold to activate TRPM8 currents (Fig-
ure S2C), suggesting that the mechanism suppressing TRPM8
activity is insensitive to the mode of TRPM8 stimulation.
To ensure physiological relevance of the measured changes in
TRPM8 currents caused by morphine or naloxone, we investi-
gated whether TRPM8 activity suppression leads to detectable
changes in intracellular Ca2+ concentration. OPRM1-transfected
HEK293M8 cells were loaded with fura-2 and analyzed as
described previously (Thebault et al., 2005). Incubation with
morphine significantly inhibited TRPM8-mediated Ca2+ entry,
whereas subsequent naloxone treatment restored it to the levels
above control (Figures 3E and 3F), in agreement with electro-
physiological observations.
Single-Channel Kinetics of TRPM8 Is Unaffected by
OPRM1 Activation
Activation of OPRM1 can suppress TRPM8 activity by modu-
lating either channel-gating properties or expression and/or
localization of TRPM8 protein. To verify the mechanism of
OPRM1-TRPM8 interaction, each of the two possibilities were
explored.
To investigate whether OPRM1 affects the TRPM8 channel
gating, we analyzed single-channel activity in HEK293 cells
expressing TRPM8 under the control of tetracycline-inducible
promoter (Thebault et al., 2005) and transfected with OPRM1,
as described above. The TRPM8 channel activity became
detectable in cell-attached patches within 4.3 hr of induction
of TRPM8 expression by tetracycline. To limit TRPM8 expression
to one channel per patch (see Figure S3 for sample of TRPM8
channel activity at various membrane potentials), the currents
were recorded within 30 min of observation of initial TRPM8
activity. Interestingly, this yielded results different from the
patches containing multiple TRPM8 channels (DRG neurons,
above), where whole-cell currents or NPopen values in outside-
out patches were clearly decreased by morphine. Now, no
discernible difference either in the current trace features or in
the generated all point histograms (Figures 4A and 4B) was
seen. Kinetic analysis of these data, carried out following the
procedures described earlier (Ferna´ndez et al., 2011), also re-
vealed no difference in the distributions of closed and open dwell
times (Figure 4C) or in the established kinetic models and Popen
(Figures 4D–4F). Thus, suppression of the TRPM8 currents
observed in the whole-cell or multiple-channel patch-clamp re-
cordings following OPRM1 activation is not caused by the mod-
ulation of the channel-gating kinetics.
Colocalization and Internalization of OPRM1 and TRPM8
Proteins
Activation of OPRM1 leads to its phosphorylation, recruitment of
b-arrestins, and internalization of the receptor. Moreover, OPRMCell Reports 4, 504–515, August 15, 2013 ª2013 The Authors 507
Figure 3. Morphine Suppresses TRPM8 Ac-
tivity in HEK293 Cells
(A) Sample I-V curves of TRPM8 current in control
(open circles) or pretreated with 10 mM morphine
for 40 min (filled squares) cells.
(B) Representative traces showing whole-cell
TRPM8 response to cold and menthol stimulation
in cells treated as indicated.
(C and D) Bar plots summarize TRPM8 responses
to cold (C) and menthol (D) in cells treated as
indicated (n = 20, 18, 12, 9, and 11). Measurements
were taken at the times indicated by vertical
arrows.
(E) Sample traces showing effect of TRPM8 stim-
ulation on cytosolic Ca2+ concentration in control
HEK293M8 cells loaded with Fura-2 (open circles)
as well as cells pretreated for 1 hr with 10 mM
morphine (black squares) followed by 1 hr treat-
ment with 10 mM naloxone (open rhombuses) or
naloxone alone (open triangles), as indicated.
(F) Barplot summarizes the effect of TRPM8 stim-
ulation on cytoplasmic Ca2+ in cells treated as
described in (E). Measurements were taken at the
peak of response, as indicated by vertical arrows
(n = 132, 81, 226 and 207). *p < 0.05, **p < 0.01,
and ***p < 0.001.
Data are presented as mean ± SEM for current
densities and mean ± SD for fluorescence ratio.
See also Figure S2.regulation is known to be agonist specific, so that regulatory
events recruited by morphine differ from those induced by other
opioids (Burford et al., 1998; McPherson et al., 2010). In partic-
ular, it was recently shown that morphine promotes interaction
of OPRM1 only with b-arrestin2 and not b-arrestin1 (Groer
et al., 2007, 2011; Li et al., 2009) and that this interaction is suf-
ficient to induce OPRM1 internalization, but not receptor ubiqui-
tination and subsequent degradation (Groer et al., 2011).
To check whether these features of OPRM1 regulation can
account for the observed suppression of TRPM8 current by
morphine, we examined the possibility of direct interaction be-
tween the two proteins and their plasmalemmal trafficking.
Coupling between OPRM1 and TRPM8 was tested using immu-
noprecipitation performed on HEK293 cells transfected with His-
tagged TRPM8 with or without OPRM1. Cell extracts were first508 Cell Reports 4, 504–515, August 15, 2013 ª2013 The Authorsimmunoprecipitated with His antibody,
and the precipitated proteins were
analyzed by immunoblotting for OPRM1.
ORPM1 was present on the beads and
was detected in the precipitated complex
(IP) with TRPM8 when both proteins were
cotransfected. Only a weak band was
detected on precipitated complex from
the cells not transfected with ORPM1
(Figure 5A).
Regulation of the TRPM8 plasmalem-
mal trafficking by morphine was as-
sessed with biotin labeling. HEK293M8
cells were transfected with OPRM1 re-
ceptor plasmid as described previouslyand treated with 10 mM morphine for 0, 10, and 40 min. Subse-
quent cell-surface biotinylation showed that morphine treatment
led to a progressive removal of TRPM8 from plasma membrane
in the cells expressing OPRM1 but not in the cells expressing
TRPM8 alone (Figure 5B). Prolonged morphine treatment only
increased removal of TRPM8 channel from the membrane,
whereas subsequent application of 10 mM naloxone for 1 hr
was sufficient to revert internalization of the channel and
permitted TRPM8 to reach the cell surface again (Figure 5C).
The results of the biotinylation and electrophysiological experi-
mentswere further confirmedbydirect visualizationof cellulardis-
tribution of immunostained TRPM8 and OPRM1 proteins in DRG
neurons usingfluorescenceconfocal imaging (Figure5D). In these
experiments, primary antibody-specific binding to TRPM8
and OPRM1 was visualized with Alexa-Fluor-488-conjugated
Figure 4. Analysis of the TRPM8 Single-Channel Activity Reveals that Morphine Does Not Alter the Channel-Gating Properties
(A) Sample activity in cell-attached patches in control (upper panel) and pretreated for 40 min with 10 mMmorphine (middle panel) HEK293 cells, contrasted by
lack of activity in noninduced (lower panel) cells.
(B) All-point histograms compare TRPM8 channel activity in cell-attached patches in control (upper panel), following morphine treatment (middle panel) and
noninduced (lower panel) cells. No apparent difference can be observed between the distributions describing activity in TRPM8-expressing cells.
(C) Closed and open dwell-time histograms summarizing measurements of single-channel activity in control (upper panels) and morphine-pretreated (middle
panels) cells (seven and six traces correspondingly). Lower panels summarizing the difference between morphine-treated and control cells reveal only minor
deviations for both closed and open dwell time distributions.
(D) Scheme representing the gating model that fits best the collected single-channel data of control cells, with morphine resulting in practically identical set of
parameters. The areas of the circles are proportional to the equilibrium occupancy of the corresponding states. Numbers next to connecting arrows indicate the
best-fit rate constants for control cells.
(E) The panel shows a difference in equilibrium occupancies between the corresponding states of morphine-pretreated and control cells. Note, that the dif-
ferences are <0.05 for all states.
(F) Bar plot compares average Popen for control and morphine-treated cells (mean ± SEM). No significant difference was observed.
See also Figure S3.immunoglobulin (Ig) G and Rhodamine-Red-X-conjugated IgG,
respectively. Immunostaining was performed in control condi-
tions and following 12 hr incubation with 10 mM morphine. This
revealed that spatial pattern of the fluorescence signal of both flu-
orophoreswas altered followingmorphine treatment fromperiph-
eral bright outline tomore homogeneouscytoplasmicdistribution,
thus confirming that activation of OPRM1 induces internalization
of the both proteins.To relate predominant peripheral appearance of TRPM8 pro-
tein to position of the plasma membrane and to monitor how it
is altered after morphine treatment, we extended our study to
the model cells where (1) the expression of TRPM8 can be visu-
alized by YFP in living cells and (2) the level of its expression can
be controlled. In these experiments, HEK293 cells were cotrans-
fected with TRPM8-YFP andOPRM1 plasmids and were imaged
36 hr later. Figure 6A compares spatial distribution profiles ofCell Reports 4, 504–515, August 15, 2013 ª2013 The Authors 509
Figure 5. Activation of Morphine Receptors
Leads to Internalization of the TRPM8
Channel
(A) OPRM1 interacts with TRPM8. Immunopre-
cipitation of the His-tagged TRPM8 was realized
using the His antibody confirmed by immunoblot-
ting against TRPM8 (right panel) and coimmuno-
precipitation with OPRM1 proteins was detected
by using the OPRM1 antibody on the immuno-
precipitated complex (IP, left panel).
(B) Surface TRPM8 expression was analyzed by
immunoblotting for the plasma membrane fraction
(TRPM8PM) and the total cell lysates (TRPM8TL)
and showed that morphine treatment leads to
decreased presence of the channel in the bio-
tinylated fraction in cells expressing OPRM1.
(C) TRPM8 internalization was reversed by 1 hr
treatment with 10 mM naloxone.
(D) Immunodetection of TRPM8 and OPRM1 pro-
teins in DRG neurons was performed in control
conditions (top) and following 12 hr incubationwith
10 mMmorphine (middle). Specificity of the primary
antibody (Ab) binding was confirmed by the
absence of fluorescence signal when primary Abs
were omitted from the immunostaining protocol
(bottom). Fluorescence images were captured
from the confocal optical slice <0.6 mm. The
galleries show phase-contrast transmitted-light
image of DRG neuron, confocal images of
Rhodamine Red-X, Alexa Fluor 488, and DAPI
fluorescence and their overlay, from left to right,
respectively.TRPM8-YFP protein in control cells and cells treated with 10 mM
morphine for 24 hr or cells treated with 10 mM naloxone for 3 hr
following the 24 hr morphine treatment. The long-term morphine
treatment led to redistribution of TRPM8 channel from plasma
membrane to cell interior. This was reversed by the follow-up
treatment with naloxone. Assessment of the dynamics of the
TRPM8 redistribution within 90 min of the drug application re-
vealed a gradual decrease of enhanced yellow fluorescent pro-
tein (eYFP) fluorescence at plasma membrane (PM) in response
to 10 mM morphine (Figure 6B), and progressive relocation of
eYFP fluorescence to PM induced by 10 mM naloxone in
morphine-pretreated cells (Figure 6C).
Knockout of TRPM8 in Mice Suppresses Morphine
Antinociceptive Action and Cold Hyperalgesia during
Morphine Withdrawal
To analyze whether morphine-dependent trafficking of TRPM8 is
related to morphine-induced cold analgesia, we compared the510 Cell Reports 4, 504–515, August 15, 2013 ª2013 The Authorsantinociceptive effect of morphine in
TRPM8/ and control mice using the
tail immersion test. In line with a previous
report (Bautista et al., 2007), we observed
higher basal withdrawal threshold in
TRPM8/mice than in WT animals, con-
firming the hyposensitivity of these KO
animals. Figure 7A shows a significant
decrease of morphine-induced cold anal-gesia in TRPM8/ mice at 5C, 10C, 15C, and 20C. Interest-
ingly, this effect was observed at all tested temperatures, with
the reduction of morphine analgesic effect ranging from 40%
when the test was carried out at 20C to 89% when the test
was carried out at 10C. Although TRPM8 serves as an important
receptor for cooling sensation (Bautista et al., 2007; Colburn
et al., 2007; Dhaka et al., 2007), a recent study (Pogorzala
et al., 2013) reports an important thermal deficit in TRPM8-DTX
mice below 15C, suggesting a potential role of the channel
even in noxious cold perception.
Further, we have tested the importance of TRPM8 in the mani-
festation of the withdrawal syndrome induced by naloxone
following a prolonged exposure to morphine (Figure 7B). The
response was assessed by the number of escape jumps, as a
measure of physical dependence (Figure 7C), and by the differ-
ence in pain thresholds using the cold-plate test, corresponding
to morphine-induced hyperalgesia (Chang et al., 2007) (Fig-
ure 7D). Interestingly, the scores were significantly decreased
Figure 6. Confocal Detection of eYFP-
TRPM8 Translocation Induced by Morphine
and Naloxone
(A–C) Confocal imaging was performed on the
HEK293 cells transfected with OPRM1 and eYFP-
TRPM8 and stained with CellMask Deep Red
(CMDR) plasma membrane stain. Cellular distri-
bution of eYFP-TRPM8 at a steady state (A) is
compared in control (left), following 24 hr incuba-
tion with 10 mM morphine (middle) and following
3 hr incubation with 20 mM naloxone after 24 hr
morphine pretreatment (right). To discriminate
between plasma membrane (PM) and intracellular
compartments, spatial patterns of eYFP and
CMDR fluorescence were related. Top: galleries
show (from left to right) images of CMDR fluores-
cence, eYFP fluorescence, and their overlay, as
indicated. Bottom: spatial profiles of eYFP (yellow
curve) and CMDR (red curve) fluorescence along
the cyan line, shown on the overlay images (top),
are compared, respectively. Note predominant
plasmalemmal localization of eYFP-TRPM8 in
control and following naloxone treatment,
and internalization of eYFP-TRPM8 caused by
morphine. Dynamics of the morphine-induced
eYFP-TRPM8 internalization (B) and its reversal by
naloxone (C) was visualized following acute drug
application. In (B) and (C), images of eYFP fluo-
rescence obtained under indicated conditions
(top) are accompanied by corresponding color-
coded shaded-surface plots (bottom, respec-
tively). At the end of the protocol, the cells were
stained with CMDR, and spatial patterns of eYFP
and CMCR fluorescence were related (galleries,
right). Note gradual decrease of eYFP fluores-
cence at PM compartment caused by morphine
(B) and redistribution of eYFP fluorescence to PM
caused by naloxone (C).in TRPM8/ mice (Figures 7C and 7D), indicating that TRPM8
channels are involved in morphine-induced physical depen-
dence and cold hyperalgesia, respectively.
DISCUSSION
In summary, our data demonstrate direct interaction between
OPRM1 and TRPM8 proteins and reveal a mechanism underly-
ing the distorted cold sensitivity upon administration of opioids.
TRPM8 is regulated by a variety of pathways involving PIP2,
iPLA2/LPLs, and G-proteins (Bavencoffe et al., 2011). Of partic-
ular interest are the mechanisms involving activation of various
receptors, such as B2R or AChR, and leading to changes in
TRPM8 activity without affecting its localization (Bavencoffe
et al., 2010; Zhang et al., 2012). However, unlike these previously
reportedmodulations, the presentedmechanism does not affect
gating properties of the channel. Instead, activation of OPRM1
leads to internalization of TRPM8 protein that could, at leastCell Reports 4, 504–515partially, explain the cold antinociceptive
effect of morphine. Initiation of drug with-
drawal effect by treating abstinent mice
with an OPRM reverse agonist, naloxone,may lead to TRPM8 reconstitution and could be linked to
increased TRPM8 activity and associated Ca2+ entry seen in
cell-culture models. Although it is possible that OPRM1 activa-
tion may also recruit the regulatory mechanism described previ-
ously (Bavencoffe et al., 2011), here we demonstrated that
TRPM8 channels are rapidly internalized following OPRM1 acti-
vation. Thus, possible regulation of the TRPM8 channel gating by
OPRM1 is of limited physiological significance, leaving the inter-
nalization as a primary means responsible for the changes
observed in vivo. In addition, such a mechanism allows us to
reconcile the observations of rapid OPRM1 desensitization and
sustained suppression of cold response. Moreover, with some
studies reporting cold-induced hyperalgesia (Wasner et al.,
2004) or analgesia (Cliff and Green, 1996) in drug addicts,
many studies of pain tolerance in opiate abusers utilizing cold-
pressor tests (Chu et al., 2006; Compton, 1994; Ren et al.,
2009) and mounting evidence of correlation between pain re-
sponses to different stimuli (Neddermeyer et al., 2008), it is, August 15, 2013 ª2013 The Authors 511
Figure 7. Strong Reduction of Morphine Antinociceptive Action as Well as Withdrawal Effect in TRPM8/ Mice
(A) Comparison of systemic morphine (3 mg/kg s.c.) analgesic effect in the tail immersion test at temperatures ranging from 5C to 20C, as indicated. Each panel
represents the kinetic curves of the pain thresholds ±SEM, and the insets show the areas under the curves ±SEM from baselines pretreatment (T = 0); n = 8–11 per
genotype.
(B–D) Evaluation of naloxone-induced withdrawal syndrome after repeated exposure of morphine by control and TRPM8/ mice treated as indicated in the
scheme shown in (B). (C) The bar plots compare the number of escape jumps, n = 10 per genotype. (D) The hyperalgesic score is calculated after precipitating
(legend continued on next page)
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interesting to speculate that distorted cold and pain sensitivity
share at least some signaling pathways. In line with this pros-
pect, the proposed mechanism could provide a basis for under-
standing changes not only in thermal sensation but also in
general analgesia associated with opiate administration and hy-
peralgesia associated with abstinence.
EXPERIMENTAL PROCEDURES
Cell Cultures and Nucleofection
Eight- to twelve-week-old Wistar rats were killed by inhalation of 100% CO2,
followed by decapitation. Twelve to fifteen DRGs from thoracic and lumbar re-
gions were dissected and incubated at 37C for 30 min in standard bath solu-
tion containing (in mM): 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, and 10
HEPES (pH 7.4), supplemented with 2 mg/ml collagenase (type 1A, Sigma-
Aldrich). The ganglia were then transferred to 0.05% trypsin/EDTA into Ca2+-
andMg2+-freeHank’s balanced salt solution for 2min at 37C.After incubation,
ganglia were washed three times with bath solution, centrifuged at 1,000 rpm
for 4 min, and resuspended in 1 ml of medium containing DMEM/Ham’s F12,
10% fetal bovine serum, and 1% penicillin/streptomycin. Dissociated cells
were obtained by trituration through a fire-polished glass Pasteur pipette,
plated onpoly-L-lysine (1mg/ml)-coatedPetri dishes (Nunc)with the sameme-
dium, andmaintained at 37C in a humidified atmosphere of 5%CO2 and 95%
air before patching. The neurons were used for recordings within next 24 hr.
HEK293M8 cells were cultured, and, where necessary, TRPM8 expression
was induced by tetracycline as described previously (Thebault et al., 2005).
For the single-channel studies, the tetracycline repressor-expressing
HEK293 cells were used, and the expression of the channel was induced
with 1 mg/ml tetracycline for 4.3 hr before use. Cells were used for patch-clamp
experiments and cell-surface biotinylation 36–48 hr after nucleofection. For
fluorescence imaging, cells were transfected with 2 mg of each construct and
0.2 mg of pmax GFP using Nucleofector (Amaxa). The constructs that have
been used are the human TRPM8pcDNA4 (Thebault et al., 2005), TRPM8
peYFP-C1 (Bidaux et al., 2012), and my-ORpIREShyg2, which was a kind gift
of Professor Michael Xi Zhu (Department of Integrative Biology and Pharma-
cology, University of Texas Health Science Center, Houston Medical School).
Patch-Clamp Recordings and Data analysis
Patch-clamp experiments were performed using Axopatch 200B amplifier and
pClamp 10.0 software (Molecular Devices) for data acquisition and analysis.
Patch pipettes were fabricated from borosilicate glass capillaries (World Pre-
cision Instruments) on horizontal puller (Sutter Instruments) and had resistance
of 2–3 MU for the whole-cell and 6–10 MU for single-channel recordings. For
the whole-cell patch-clamp recordings, DRG neurons and HEK293M8 cells
were bathed in the standard extracellular solution (in mM): 140 NaCl, 5 KCl,
10 glucose, 10 HEPES, 2 CaCl2, and 2 MgCl2 (pH 7.4). The pipettes were filled
with Cs-based intracellular solution tominimize background outward currents,
(in mM): 140 CsCl, 5 EGTA, 10 HEPES, pH adjusted to 7.3 with Cs(OH), sup-
plemented by 2 mM Mg-ATP, and 0.5 mM Li-GTP in the case of recordings
on DRG neurons.
Single-channel recordings were carried in outside-out patches made to
DRG neurons and cell-attached patches to HEK293M8 cells. Cells were
immersed in hi-K solution (in mM: 150 KCl, 5 glucose, 10 HEPES, 1 CaCl2, 2
MgCl2 [pH 7.3], adjusted with KOH) in order to keep membrane potential close
to zero. Pipettes were filled with the same KCl solution, to keep recording con-
ditions symmetrical, and supplemented with 100 mMmenthol to match whole-
cell stimulation of TRPM8 and, in case of cell-attached recordings of
morphine-suppressed currents in HEK293M8 cells, with 10 mM morphine.
Recorded activity was quantified by performing a single-channel search
analysis using the Clampfit-10 (pClamp software suit, Molecular Devices)withdrawal syndrome bymeasuring the difference between pain thresholds of mic
those that received saline, using cold-plate test. Note, that wild-type mice that
exposure than vehicle-treated mice and that this hyperalgesic effect is absent in
Data are presented as mean ± SEM. **p < 0.01 and ***p < 0.001, respectively.and QuB 2.0 programs. Stimulation of TRPM8 by both mild cold and applica-
tion of 100 mM of menthol led to high level of TRPM8 activity, with typical Popen
in excess of 0.5 (Ferna´ndez et al., 2011), see also Figure S3 for sample TRPM8
activity at different membrane potentials). Therefore, simple rejection of traces
that, at any point, exhibited multiple conductance levels provided a reliable
way to select appropriate traces.
Statistical analyses, t tests, and Gaussian fits to amplitude distributions
were carried out using the Microcal Origin software. Values are expressed
as mean ± SEM, unless indicated otherwise.
Calcium Microfluorometry
Calcium microfluorometry experiments were performed as described previ-
ously (Thebault et al., 2005). Briefly, the cytosolic Ca2+ concentration
([Ca2+]i) was measured using the ratiometric dye Fura-2 and is reported as
f/f0. The bath solution was the same one used to record TRPM8 currents.
Immunodetection and Biotynilation
Immunocytochemistry as well as immunoprecipitation, biotinylation, and
immunoblotting was performed as described previously (Bavencoffe et al.,
2010; Gkika et al., 2010; McKemy et al., 2002; Thebault et al., 2005). Detailed
description is available in the Extended Experimental Procedures.
Confocal Microscopy
Experimental chambers with cells were placed on the stage of Axiovert 200M
inverted microscope attached to LSM 510 META laser-scanning unit (Zeiss).
The SCSI interface of the confocal microscope was hosted by a Pentium PC
(32-bit Windows NT 4.0 operating system) running LSM 510 software (Zeiss).
Confocal imaging was performed as previously described (Bolton and Gor-
dienko, 1998; Gordienko et al., 2008; Povstyan et al., 2011). Detailed descrip-
tion is available in the Extended Experimental Procedures.
Animals and In Vivo Studies
Two-month-old Wistar rats were obtained from Harlan Laboratories, France.
Animals were killed by inhalation of 100% CO2, followed by decapitation.
These procedures were approved by the local Institutional Animal Care and
Use Committee.
All experimentswereperformedon20–24gmaleC57Bl/6Jmice (CharlesRiver
Laboratories) and TRPM8–/– mice (kind gift of Prof. D. Julius, UCSF). Animals
were acclimatized to the laboratory conditions for at least 1week prior to testing.
They were housed in grouped cages in a temperature-controlled environment
with foodandwater ad libitum.Thebehavioral experimentswereperformedblind
to the genotype, in a quiet room, by the same experimenter for a given test taking
great care to avoid or minimize discomfort of the animals. Treatments were ran-
domized, and all experimentswere carried out according to the guidelines of the
Committee for Research and Ethical Issues of IASP (Zimmermann, 1983).
Tail immersion test was performed as described earlier (Janssen et al.,
1963). In brief, the water temperature was kept constant at 5C, 10C, 15C,
or 20C ± 0.2C by using a thermoregulated water bath. Mice were maintained
under a soft cloth excepting their tail, which was immersed in the water until
withdrawal was observed (cutoff time of 40 s). They were injected subcutane-
ously (s.c.) with 3mg/kgmorphine, and tail withdrawal latencieswere recorded
immediately before and 15, 30, 45, 60, and 90 min after treatment.
Naloxone-precipitated withdrawal was precipitated as described (Ren et al.,
2004). Briefly, mice were first given twice daily morphine injections (10 mg/kg,
s.c.) for 6 days (only one injection at day 6 however) Withdrawal was precipi-
tated on day 6 by injecting naloxone (2 mg/kg, intraperitoneally) 2 hr after
the final administration of morphine. Ten minutes before naloxone treatment,
mice were placed in a transparent acrylic box (20 cm in diameter, 60 cm
high) to habituate to the new environment. Immediately after naloxone chal-
lenge, each mouse was placed gently again in the box, and the number of
escape jumps (the most characteristic naloxone-precipitated withdrawale that have been administered with high-dose morphine regimen, compared to
were treated with morphine exhibited a significantly higher sensitivity to cold
the TRPM8/ animals, n = 5–7 per genotype.
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sign) was recorded for 30 min. For the cold-plate test, a Hot Cold Plate Anal-
gesia Meter (Bioseb) was used. Mice were placed on a plate with surface tem-
perature maintained at 0C, and the behavior was recorded by experimenter
blind to the genotype. Nocifensive behavior was quantitatively evaluated by
counting the latency to the first jump (Karashima et al., 2009).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
three figures and can be found with this article online at http://dx.doi.org/10.
1016/j.celrep.2013.07.002.
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